Trial : NL83392.078.23

Trial : NL83392.078.23 - NL83392.078.23

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON53922

Enrollment

Registered

2023-02-13

Start date

2024-04-22

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Ovarian Cancer / Ovarian Cancer

Interventions

Publication withdrawn by sponsor

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Publication withdrawn by sponsor

Exclusion criteria

Exclusion criteria: Publication withdrawn by sponsor

Design outcomes

Primary

Measure	Time frame
Publication withdrawn by sponsor	—

Secondary

Measure	Time frame
Publication withdrawn by sponsor	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)